澳大利亚皮肤癌风险评估系统（AUSDRISK）——在全科医疗中的应用
AUSDRISK - application in general practice.
作者信息
Wong Kam Cheong, Brown Anthony M, Li Stephen C H
机构信息
Beyond Medical Education, University of Sydney, Bathurst, New South Wales, Australia.
出版信息
Aust Fam Physician. 2011 Jul;40(7):524-6.
BACKGROUND
The Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) has been promoted since July 2008. We studied its application rate and the profile of a sample of general practice patients within Central West New South Wales from June to December 2010.
METHODS
Stage one assessed the awareness and application of AUSDRISK among general practitioners and general practice registrars. In stage two, the doctors used AUSDRISK and appropriate blood tests to screen patients aged 25-74 years who had not been previously diagnosed with diabetes.
RESULTS
Seventy-eight doctors (response rate 45.1%) completed the survey. A total of 68.2% of general practice registrars and 23.2% of GPs were aware of AUSDRISK. Among the respondents 14.1% (95% CI: 6-22%) applied AUSDRISK in their usual practice, and 39.1% (95% CI: 31-47%) of the 151 patients had high AUSDRISK scores ≥15.
DISCUSSION
Two years after the launch of AUSDRISK, the application rate of AUSDRISK is low. In this patient population, many patients had high AUSDRISK scores.
背景
自2008年7月起澳大利亚2型糖尿病风险评估工具（AUSDRISK）开始推广。我们研究了2010年6月至12月新南威尔士州中西部地区全科医疗患者样本中该工具的应用率及其特征。
方法
第一阶段评估全科医生和全科医疗住院医生对AUSDRISK的知晓程度和应用情况。第二阶段，医生使用AUSDRISK及适当的血液检测对25至74岁、既往未被诊断为糖尿病的患者进行筛查。
结果
78名医生（回复率45.1%）完成了调查。共有68.2%的全科医疗住院医生和23.2%的全科医生知晓AUSDRISK。在受访者中，14.1%（95%置信区间：6 - 22%）在日常工作中应用了AUSDRISK，151名患者中有39.1%（95%置信区间：31 - 47%）的AUSDRISK得分≥15，属于高风险。
讨论
AUSDRISK推出两年后，其应用率较低。在该患者群体中，许多患者的AUSDRISK得分较高。
Zotero 插件